The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study

Introduction: Medical comorbidities influence survival in CLL. We previously reported on a simplified CLL-specific comorbidity scale, the CLL-CI (Gordon et al. 2019), which required assessment of only three organ systems and was predictive of outcomes in a heterogeneous retrospective patient cohort....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2020-11, Vol.136 (Supplement 1), p.1-3
Hauptverfasser: Gordon, Max J., Kaempf, Andy, Sitlinger, Andrea, Salous, Tareq, Alqahtani, Hamood, Churnetski, Michael C., Wisniewski, Paul, Rivera, Xavier Issac, Patel, Krish, Persky, Daniel O., Cohen, Jonathon B., Choi, Michael Y., Hill, Brian T., Shadman, Mazyar, Stephens, Deborah M., Brander, Danielle M., Park, Byung, Danilov, Alexey
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!